Bayer to Present Data from Cardiovascular Portfolio, Includi

Bayer to Present Data from Cardiovascular Portfolio, Including Finerenone

(PLX AI) - Bayer to present data from cardiovascular portfolio, including late breaking data from Phase III FIGARO-DKD (finerenone) and various Xarelto studies at the ESC Congress 2021.• A total of three

Related Keywords

, Bayer , Present , Data , Rom , Ardiovascular , Portfolio , Ncluding , Finerenone , பேயர் , அட்டா , ரோம் ,

© 2025 Vimarsana